Poseida Therapeutics Inc.
Company facts
- Founded
- 2014
- Headquarters
- United States
- CEO
- Kristin Yarema, Ph.D.
About
At Poseida Therapeutics, we are boldly developing new solutions to redefine treatment paradigms for life-threatening cancers and genetic diseases. We have designed our genetic engineering technologies to represent the future of innovation in cell and gene therapies, giving new hope to patients. Our proprietary non-viral technology platforms, including the piggyBac® DNA delivery system, enable the insertion of large genetic payloads into the genome. This empowers our therapies to reach various types of cancer and genetic disorders. Our leadership team combines long-standing scientific expertise with the strategic insight needed to move the company forward and deliver novel therapeutics for patients. Poseida is at the forefront of the clinical-stage biopharmaceutical field, focusing on developing advanced allogeneic cell therapies that utilize a differentiated approach to combat disease. As we continue our journey, we remain committed to making a significant impact in the lives of people suffering from serious illnesses.
Machine Learning Scientist, Scientific Reasoning Models, AI for Drug Discovery
The Position A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we…
Principal Supply Chain Data Scientist
The Position The Company Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 45 years. Genentech is a biotechnology…